Sponsored

Radiopharm Theranostics (ASX: RAD) to showcase innovations at B. Riley Securities Radiopharma Investor Conference

February 23, 2024 12:56 AM GMT | By Team Kalkine Media
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 Radiopharm Theranostics (ASX: RAD) to showcase innovations at B. Riley Securities Radiopharma Investor Conference

Highlights

  • RAD has secured a spot at B. Riley Securities Event for radiopharmaceutical advancements.
  • The event will feature over 15 small-to-mid cap public and private companies from the CDMO, industrial, biotech, medtech, and medical services space.

Radiopharm Theranostics (ASX:RAD) is excited to announce its invitation to participate in the B. Riley Securities Radiopharma Investor Conference on 1 March 2024. This event is scheduled to take place in New York.

Over 15 public and private companies (small-to-mid cap) focused on introducing life-saving radiotherapeutics and imaging agents to the market will participate in the event. These companies are from the medtech, medical services, biotech, CDMO (contract development & manufacturing organization), and industrial space.   

During the conference, Radiopharm's management will deliver an exclusive presentation about the company, and they will also participate in a panel discussion addressing imaging in radiopharmaceuticals. This opportunity allows them to engage with various institutional and professional investors from the United States, providing valuable insights into the company's advancements and contributions to the field.

RAD is a clinical-stage biopharmaceutical company dedicated to advancing innovative radiopharmaceuticals in areas with significant medical needs.

RAD shares traded at AU$0.058 on 22 February 2024.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

AI on the Rise: A Look at Top AI Companies and Their Stocks

Recent Articles

Investing Tips

Previous Next